Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) - Total Assets

Latest as of March 2026: CN¥6.02 Billion CNY ≈ $880.77 Million USD

Based on the latest financial reports, Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) holds total assets worth CN¥6.02 Billion CNY (≈ $880.77 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Wuhan Easy Diagnosis Biomedicine Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A - Total Assets Trend (2011–2025)

This chart illustrates how Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's total assets have evolved over time, based on quarterly financial data. Check Wuhan Easy Diagnosis Biomedicine Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A - Asset Composition Analysis

Current Asset Composition (December 2025)

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's total assets of CN¥6.02 Billion consist of 78.3% current assets and 21.7% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	8.5%
Accounts Receivable	CN¥466.40 Million	7.8%
Inventory	CN¥65.10 Million	1.1%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥26.54 Million	0.4%
Goodwill	CN¥0.00	0.0%

Asset Composition Trend (2011–2025)

This chart illustrates how Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Wuhan Easy Diagnosis Biomedicine Co Ltd stock valuation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's current assets represent 78.3% of total assets in 2025, an increase from 77.1% in 2011.
Cash Position: Cash and equivalents constituted 8.5% of total assets in 2025, down from 32.1% in 2011.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2011.
Asset Diversification: The largest asset category is accounts receivable at 7.8% of total assets.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Competitors by Total Assets

Key competitors of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A based on total assets are shown below.

Company	Country	Total Assets
SS Innovations International Inc. Common Stock NASDAQ:SSII	USA	$90.55 Million
Medacta Group SA SW:MOVE	Switzerland	CHF860.76 Million
Double Medical Technology Inc SHE:002901	China	CN¥5.03 Billion
Shenzhen New Industries Biomedical SHE:300832	China	CN¥9.58 Billion
Jafron Biomedical Co Ltd SHE:300529	China	CN¥5.52 Billion
Sinocare Inc SHE:300298	China	CN¥6.25 Billion
Xiangyu Medical Co. Ltd. A SHG:688626	China	CN¥3.27 Billion
INKON Life Technology Co Ltd SHE:300143	China	CN¥4.17 Billion

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	18.35	10.22	7.05
Quick Ratio	17.98	10.04	6.25
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥4.44 Billion	CN¥3.89 Billion	CN¥1.51 Billion

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A - Advanced Valuation Insights

This section examines the relationship between Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	0.72
Latest Market Cap to Assets Ratio	0.08
Asset Growth Rate (YoY)	-9.3%
Total Assets	CN¥5.98 Billion
Market Capitalization	$506.97 Million USD

Valuation Analysis

Below Book Valuation: The market values Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's assets below their book value (0.08x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's assets decreased by 9.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2011–2025)

The table below shows the annual total assets of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2011 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥5.98 Billion ≈ $875.11 Million	-9.29%
2024-12-31	CN¥6.59 Billion ≈ $964.77 Million	-10.74%
2023-12-31	CN¥7.39 Billion ≈ $1.08 Billion	-19.63%
2022-12-31	CN¥9.19 Billion ≈ $1.34 Billion	+168.97%
2021-12-31	CN¥3.42 Billion ≈ $500.03 Million	+139.52%
2020-12-31	CN¥1.43 Billion ≈ $208.76 Million	+123.46%
2019-12-31	CN¥638.42 Million ≈ $93.42 Million	+3.45%
2018-12-31	CN¥617.15 Million ≈ $90.31 Million	+140.57%
2017-12-31	CN¥256.54 Million ≈ $37.54 Million	+30.13%
2016-12-31	CN¥197.15 Million ≈ $28.85 Million	+47.17%
2015-12-31	CN¥133.96 Million ≈ $19.60 Million	+119.56%
2014-12-31	CN¥61.01 Million ≈ $8.93 Million	+156.45%
2013-12-31	CN¥23.79 Million ≈ $3.48 Million	+410.85%
2012-12-31	CN¥4.66 Million ≈ $681.46K	+137.91%
2011-12-31	CN¥1.96 Million ≈ $286.44K	--

About Wuhan Easy Diagnosis Biomedicine Co Ltd Class A

SHE:002932 China Medical Devices

Market Cap

$506.97 Million

CN¥3.46 Billion CNY

Market Cap Rank

#12319 Global

#3605 in China

Share Price

CN¥14.90

Change (1 day)

+0.20%

52-Week Range

CN¥14.75 - CN¥22.86

All Time High

CN¥49.58